194 related articles for article (PubMed ID: 19216628)
21. Evolution of R-CHOP therapy for older patients with diffuse large B-cell lymphoma.
Morrison VA
Expert Rev Anticancer Ther; 2008 Oct; 8(10):1651-8. PubMed ID: 18925856
[TBL] [Abstract][Full Text] [Related]
22. Primary gastric lymphoma of T-cell origin: clinicopathologic features and treatment outcome.
Park YH; Kim WS; Bang SM; Lee SI; Kang HJ; Na II; Yang SH; Lee SS; Uhm JE; Kwon JM; Kim K; Jung CW; Park K; Ko YH; Ryoo BY
Leuk Res; 2006 Oct; 30(10):1253-8. PubMed ID: 16529813
[TBL] [Abstract][Full Text] [Related]
23. The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphoma.
Ferreri AJ; Dognini GP; Bairey O; Szomor A; Montalbán C; Horvath B; Demeter J; Uziel L; Soffietti R; Seymour JF; Ambrosetti A; Willemze R; Martelli M; Rossi G; Candoni A; De Renzo A; Doglioni C; Zucca E; Cavalli F; Ponzoni M;
Br J Haematol; 2008 Oct; 143(2):253-7. PubMed ID: 18699850
[TBL] [Abstract][Full Text] [Related]
24. Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma.
Colovic N; Jurisic V; Terzic T; Atkinson HD; Colovic M
Arch Dermatol Res; 2009 Oct; 301(9):689-92. PubMed ID: 19495780
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcome of primary gastric lymphoma treated with chemotherapy alone or surgery followed by chemotherapy.
Chang MC; Huang MJ; Su YW; Chang YF; Lin J; Hsieh RK
J Formos Med Assoc; 2006 Mar; 105(3):194-202. PubMed ID: 16520834
[TBL] [Abstract][Full Text] [Related]
26. Rituximab therapy in malignant lymphoma.
Coiffier B
Oncogene; 2007 May; 26(25):3603-13. PubMed ID: 17530014
[TBL] [Abstract][Full Text] [Related]
27. CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: results of the HE22A99 trial of the Hellenic Cooperative Oncology Group.
Economopoulos T; Psyrri A; Dimopoulos MA; Kalogera-Fountzila A; Pavlidis N; Tsatalas C; Nikolaides C; Mellou S; Xiros N; Fountzilas G
Cancer J; 2007; 13(5):327-34. PubMed ID: 17921732
[TBL] [Abstract][Full Text] [Related]
28. DNA repair gene XRCC1 polymorphisms and haplotypes in diffuse large B-cell lymphoma in a Korean population.
Kim IS; Kim DC; Kim HG; Eom HS; Kong SY; Shin HJ; Hwang SH; Lee EY; Kim S; Lee GW
Cancer Genet Cytogenet; 2010 Jan; 196(1):31-7. PubMed ID: 19963133
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment with modified CHOP-rituximab in pediatric AIDS-related advanced stage Burkitt lymphoma.
Crosswell HE; Bergsagel DJ; Yost R; Lew G
Pediatr Blood Cancer; 2008 Apr; 50(4):883-5. PubMed ID: 17278123
[TBL] [Abstract][Full Text] [Related]
30. Rituximab as monotherapy and in addition to reduced CHOP in children with primary immunodeficiency and non-Hodgkin lymphoma.
Shabbat S; Aharoni J; Sarid L; Ben-Harush M; Kapelushnik J
Pediatr Blood Cancer; 2009 May; 52(5):664-6. PubMed ID: 19142990
[TBL] [Abstract][Full Text] [Related]
31. Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type.
Salar A; Domingo-Domenech E; Estany C; Canales MA; Gallardo F; Servitje O; Fraile G; Montalbán C
Cancer; 2009 Nov; 115(22):5210-7. PubMed ID: 19672998
[TBL] [Abstract][Full Text] [Related]
32. Rituximab and chemotherapy in diffuse large B-cell lymphoma.
Sonet A; Bosly A
Expert Rev Anticancer Ther; 2009 Jun; 9(6):719-26. PubMed ID: 19496708
[TBL] [Abstract][Full Text] [Related]
33. Salvage therapy for relapsed posttransplant lymphoproliferative disorders (PTLD) with a second progression of PTLD after Upfront chemotherapy: the role of single-agent rituximab.
Trappe RU; Choquet S; Reinke P; Dreyling M; Mergenthaler HG; Jäger U; Kebelmann-Betzing C; Jonas S; Lehmkuhl H; Anagnostopoulos I; Leblond V; Hetzer R; Dörken B; Riess H; Oertel S
Transplantation; 2007 Dec; 84(12):1708-12. PubMed ID: 18165786
[TBL] [Abstract][Full Text] [Related]
34. Primary penile diffuse large B cell lymphoma treated by local excision followed by rituximab-containing chemotherapy.
Kim HY; Oh SY; Lee S; Lee DM; Kim SH; Kwon HC; Hong SH; Yoon JH; Kim HJ
Acta Haematol; 2008; 120(3):150-2. PubMed ID: 19039206
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of diffuse large B-cell lymphoma].
Gleissner B; Zwick C; Pfreundschuh M
Dtsch Med Wochenschr; 2008 Sep; 133(36):1785-94; quiz 1795-6. PubMed ID: 18767006
[TBL] [Abstract][Full Text] [Related]
36. Failure of CHOP with rituximab for lymphomatoid granulomatosis.
Oosting-Lenstra SF; van Marwijk Kooy M
Neth J Med; 2007 Dec; 65(11):442-7. PubMed ID: 18079567
[TBL] [Abstract][Full Text] [Related]
37. [The value of radiotherapy in the treatment of aggressive and localised gastric lymphomas].
Ben Salah H; Ghorbel L; Krichen MS; Bellaaj H; Elloumi M; Frikha M; Daoud J
Cancer Radiother; 2009 Jan; 13(1):11-6. PubMed ID: 19091618
[TBL] [Abstract][Full Text] [Related]
38. Interaction between BCL2 and interleukin-10 gene polymorphisms alter outcomes of diffuse large B-cell lymphoma following rituximab plus CHOP chemotherapy.
Park YH; Sohn SK; Kim JG; Lee MH; Song HS; Kim MK; Jung JS; Lee JJ; Kim HJ; Kim DH
Clin Cancer Res; 2009 Mar; 15(6):2107-15. PubMed ID: 19276283
[TBL] [Abstract][Full Text] [Related]
39. Dose-intense treatment of mantle cell lymphoma: can durable remission be achieved?
Dreyling M; Hiddemann W
Curr Opin Oncol; 2008 Sep; 20(5):487-94. PubMed ID: 19106649
[TBL] [Abstract][Full Text] [Related]
40. High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients.
Oriol A; Ribera JM; Bergua J; Giménez Mesa E; Grande C; Esteve J; Brunet S; Moreno MJ; Escoda L; Hernandez-Rivas JM; Hoelzer D
Cancer; 2008 Jul; 113(1):117-25. PubMed ID: 18457327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
